Zomed Pharm

ZOM AMEX
0.2500
0.0000
0.00%
Closed 16:00 07/23 EDT
Open
0.2510
Prev Close
0.2500
High
0.2600
Low
0.2500
Volume
69.11K
Avg Vol (3M)
393.84K
52 Week High
2.400
52 Week Low
0.1996
% Turnover
0.06%
Market Cap
27.01M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Zomed Pharm ZOM stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Zomedica Pharmaceuticals Corp., formerly Wise Oakwood Ventures Inc., is a veterinary pharmaceutical and healthcare solutions company. The Company's principal business relates to the discovery, development and commercialization of pharmaceuticals for the companion pet. The Company's first product candidate, ZM-012, is a tablet formulation of metronidazole, an anti-infective for the treatment of diarrhea in canines (dogs). The Company's second product candidate, ZM-006, is a transdermal gel that delivers its active pharmaceutical ingredient, methimazole, which is used in veterinary medicine to treat hyperthyroidism in felines (cats). The Company's third product candidate, ZM-007, is an oral suspension formulation of metronidazole for accurate dosing of small dog breeds and puppies. The Company's fourth product candidate, ZM-011 is a transdermal gel of fluoxetine, Prozac, prescribed to treat cat behavioral disorders, such as inappropriate urination.
MORE >

Recently

Name
Price
%Change